Adequan 250 mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

adequan 250 mg/ml solution for injection

novartis animal health uk ltd - polysulphated glycosaminoglycan - solution for injection - 250 mg/ml - n.s.a.i.d - equine - food

Aldurazyme European Union - English - EMA (European Medicines Agency)

aldurazyme

sanofi b.v. - laronidase - mucopolysaccharidosis i - other alimentary tract and metabolism products, - aldurazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis i (mps i; alpha-l-iduronidase deficiency) to treat the nonneurological manifestations of the disease.

Elaprase European Union - English - EMA (European Medicines Agency)

elaprase

takeda pharmaceuticals international ag ireland branch - idursulfase - mucopolysaccharidosis ii - other alimentary tract and metabolism products, - elaprase is indicated for the long-term treatment of patients with hunter syndrome (mucopolysaccharidosis ii, mps ii). heterozygous females were not studied in the clinical trials.

Naglazyme European Union - English - EMA (European Medicines Agency)

naglazyme

biomarin international limited - galsulfase - mucopolysaccharidosis vi - other alimentary tract and metabolism products, - naglazyme is indicated for long-term enzyme-replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis vi (mps vi; n-acetylgalactosamine-4-sulfatase deficiency; maroteaux-lamy syndrome) (see section 5.1). as for all lysosomal genetic disorders, it is of primary importance, especially in severe forms, to initiate treatment as early as possible, before appearance of non-reversible clinical manifestations of the disease. a key issue is to treat young patients aged

AQUATO INTENSIVE CALMINGLOTION- adenosine lotion United States - English - NLM (National Library of Medicine)

aquato intensive calminglotion- adenosine lotion

natural story co.,ltd. - undaria pinnatifida (unii: icv1ok7m1s) (undaria pinnatifida - unii:icv1ok7m1s), hydrolyzed glycosaminoglycans (bovine; 50000 mw) (unii: 997385v0vv) (hydrolyzed glycosaminoglycans (bovine; 50000 mw) - unii:997385v0vv) - special skincare for dry and sensitive skin with abundant moisture and sea algae extract apply proper amount to the skin

Integra Dermal Regeneration Template - Skin regeneration template, human-/animal-derived Australia - English - Department of Health (Therapeutic Goods Administration)

integra dermal regeneration template - skin regeneration template, human-/animal-derived

integra neurosciences pty ltd - 46170 - skin regeneration template, human-/animal-derived - a bilayer membrane system for skin replacement. the dermal replacement layer is made of a porous matrix of fibers of cross-linked bovine tendon collagen and glycosaminoglycan (chondroitin-6-sulfate) that is manufactured with a controlled porosity and defined degradation rate. the epidermal substitute layer is made of a thin polysiloxane (silicone) layer to control moisture loss from the wound. it is indicated for the post excisional treatment of full-thickness and partial-thickness injuries where sufficient auto graft is not available at the time of excision or not desirable due to the physiological condition of the patient. integra dermal regeneration template is also indicated for use in reconstruction of post excisional, full-thickness defects of the integument where there is, in the opinion of the treating surgeon, a potential benefit to the patient by improving the reconstructive outcome or decreasing their mortality/morbidity.

Integra Dermal Regeneration Template single layer - Skin regeneration template, human-/animal-derived Australia - English - Department of Health (Therapeutic Goods Administration)

integra dermal regeneration template single layer - skin regeneration template, human-/animal-derived

integra neurosciences pty ltd - 46170 - skin regeneration template, human-/animal-derived - a porous matrix of fibers of cross-linked bovine tendon collagen and a glycosaminoglycan (chondroitin-6-sulfate) that is manufactured with a controlled porosity and defined degradation rate. indicated to add extra thickness where required (to the integra bi-layer dermal replacement) for the postexcisional treatment of full thickness and partial-thickness injuries where sufficient autograft is not available at the time of excision or not desirable due to the physiological condition of the patient. it is also indicated for use in reconstruction of postexcisional, full-thickness defects of the integument where there is, in the opinion of the treating surgeon, a potential benefit to the patient by improving the reconstructive outcome or decreasing their mortality/morbidity.

SYNOVAN INJECTION FOR DOGS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

synovan injection for dogs

ceva animal health pty ltd - acetyl glucosamine; pentosan polysulfate sodium - parenteral liquid/solution/suspension - acetyl glucosamine carbohydrate-glucose active 160.0 mg/ml; pentosan polysulfate sodium mineral-sodium active 100.0 mg/ml - musculoskeletal system - dog | bitch | castrate | puppy - inflammatory joint disease | non-infectious joint disease

NATURE'S ANSWER PERNAEASE POWDER Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nature's answer pernaease powder

mavlab pty. ltd. - shark cartilage; abalone powder; stabilised green-lipped mussel powder - oral bolus, chewable - shark cartilage extract-animal active 200.0 g/kg; abalone powder food-general active 200.0 g/kg; stabilised green-lipped mussel powder vitamin active 600.0 g/kg - musculoskeletal system - dog | bitch | castrate | puppy - arthritis